{"title":"抗转移药物的发展，更多动物模型的应用","authors":"D. Lu, Tingren Lu","doi":"10.30654/mjps.10011","DOIUrl":null,"url":null,"abstract":"Neoplasm metastasis is a multiple-step and multi-molecular pathogenesis process resisting to current norm of therapeutics. More seriously, there is a great shortage of effective and licensed anti-metastatic drugs worldwide. Several evaluative avenues of pharmaceutical efforts might change this scenario in the future. Preclinical tumor models in vivo are workable to embrace new therapeutic strategies and paradigms in the clinic. This Editorial provides latest views of advanced metastatic models in","PeriodicalId":251442,"journal":{"name":"Mathews Journal of Pharmaceutical Science","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-Metastatic Drug Developments, Utility of More Animal Models\",\"authors\":\"D. Lu, Tingren Lu\",\"doi\":\"10.30654/mjps.10011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Neoplasm metastasis is a multiple-step and multi-molecular pathogenesis process resisting to current norm of therapeutics. More seriously, there is a great shortage of effective and licensed anti-metastatic drugs worldwide. Several evaluative avenues of pharmaceutical efforts might change this scenario in the future. Preclinical tumor models in vivo are workable to embrace new therapeutic strategies and paradigms in the clinic. This Editorial provides latest views of advanced metastatic models in\",\"PeriodicalId\":251442,\"journal\":{\"name\":\"Mathews Journal of Pharmaceutical Science\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mathews Journal of Pharmaceutical Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30654/mjps.10011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mathews Journal of Pharmaceutical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30654/mjps.10011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anti-Metastatic Drug Developments, Utility of More Animal Models
Neoplasm metastasis is a multiple-step and multi-molecular pathogenesis process resisting to current norm of therapeutics. More seriously, there is a great shortage of effective and licensed anti-metastatic drugs worldwide. Several evaluative avenues of pharmaceutical efforts might change this scenario in the future. Preclinical tumor models in vivo are workable to embrace new therapeutic strategies and paradigms in the clinic. This Editorial provides latest views of advanced metastatic models in
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
